Anti-fibrotic pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; antifungal pharmaceutical preparations; antiviral pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of hiv infection; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, ulcerative colitis; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations namely, anti-inflammatories;
REGISTERED
on 05 Feb 2024
BAKFIBRO
GILEAD SCIENCES IRELAND UC
2169395 · 28 Feb 2022
005
Class 005
Pharmaceutical Products
Anti-fibrotic pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; antifungal pharmaceutical preparations; antiviral pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of hiv infection; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, crohn's disease, irritable bowel syndrome; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, ulcerative colitis; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of hepatitis; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations namely, anti-inflammatories;
